Most cited papers in Advanced Glycation End Products research
What are the most cited papers in Advanced Glycation End Products research?
The most cited paper in Advanced Glycation End Products research is "Biochemistry and molecular cell biology of diabetic complications" (Michael Brownlee, 2001), with 9,153 citations. Next come "Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study" (9,131) and "Neuroinflammation in Alzheimer's disease" (6,318).
Showing 50 of 98 papers. Every paper with more than 1,028 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Biochemistry and molecular cell biology of diabetic complications Michael Brownlee · Nature | 13 Dec 2001 | 9,153 |
| 2 | Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study IRENE M. STRATTON · BMJ | 12 Aug 2000 | 9,131 |
| 3 | Neuroinflammation in Alzheimer's disease Michael Thomas Heneka et al. · The Lancet Neurology | 16 Mar 2015 | 6,318 |
| 4 | Oxidative Stress and Diabetic Complications Ferdinando Giacco, Michael Brownlee · Circulation Research | 28 Oct 2010 | 5,514 |
| 5 | Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Takeshi Nishikawa, Diane Edelstein, Xue Liang Du et al. · Nature | Apr 2000 | 4,302 |
| 6 | Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Paola Scaffidi, Tom Misteli, Marco Emilio Bianchi · Nature | 11 Jul 2002 | 4,239 |
| 7 | Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin Lyudmila V. Borovikova, Svetlana Ivanova, Minghuang Zhang et al. · Nature | May 2000 | 4,235 |
| 8 | Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children Anshu Gupta, Jaime Uribarri · Hormone Research in Paediatrics | 2016 | 4,017 |
| 9 | Role of Oxidative Stress in Development of Complications in Diabetes John Baynes · Diabetes | Apr 1991 | 3,719 |
| 10 | Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression Masahiro Nezu, Norio Suzuki, Masayuki P. Yamamoto · American Journal of Nephrology | 2017 | 3,459 |
| 11 | HMG-1 as a Late Mediator of Endotoxin Lethality in Mice Haichao Wang, Ona Bloom, Minghuang Zhang et al. · Science | 9 Jul 1999 | 3,422 |
| 12 | Resveratrol Reduces the Proinflammatory Effects and Lipopolysaccharide- Induced Expression of HMGB1 and TLR4 in RAW264.7 Cells Ying Yang, Shuping Li, Qiao Yang et al. · Cellular Physiology and Biochemistry | 2014 | 3,256 |
| 13 | Diabetes, oxidative stress, and antioxidants: A review Alice C. Maritim, Ruth A. Sanders, J. B. Watkins · Journal of Biochemical and Molecular Toxicology | 2003 | 3,140 |
| 14 | Mechanisms of Diabetic Complications Josephine Maree Forbes, Mark Emmanuel Cooper · Physiological Reviews | 2013 | 2,890 |
| 15 | DAMPs, PAMPs and alarmins: all we need to know about danger Marco Emilio Bianchi · Journal of Leukocyte Biology | 10 Oct 2006 | 2,790 |
| 16 | A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress Daniele Del Rio, Amanda Janis Stewart, Nicoletta Pellegrini · Nutrition Metabolism and Cardiovascular Diseases | 29 Jul 2005 | 2,741 |
| 17 | Protein Oxidation and Aging Earl R. Stadtman · Science | 28 Aug 1992 | 2,701 |
| 18 | Advanced glycation end-products: a review Ravinder Singh, Anne E. Barden, Trevor Anthony Mori et al. · Diabetologia | 5 Feb 2001 | 2,606 |
| 19 | The Beclin 1 network regulates autophagy and apoptosis Raehui Kang, Herbert J. Zeh, Michael T. Lotze et al. · Cell Death and Differentiation | 11 Feb 2011 | 2,537 |
| 20 | High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal Michael T. Lotze, Kevin J. Tracey · Nature reviews. Immunology | Apr 2005 | 2,533 |
| 21 | Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications Jeffrey S. Flier, Lisa H. Underhill, Michael Brownlee et al. · New England Journal of Medicine | 19 May 1988 | 2,526 |
| 22 | Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes Louis Monnier, Emilie Mas, Christine Ginet et al. · JAMA | 11 Apr 2006 | 2,484 |
| 23 | Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. John Baynes, Suzanne R. Thorpe · Diabetes | 1999 | 2,449 |
| 24 | Advanced Glycation End Products Alison H. Goldin, Joshua A. Beckman, Ann Marie Schmidt et al. · Circulation | 7 Aug 2006 | 2,265 |
| 25 | Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes Joseph L. Evans, Ira D. Goldfine, Betty A. Maddux et al. · Endocrine Reviews | Oct 2002 | 2,239 |
| 26 | RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease Shi Du Yan, Xi Chen, Jin Fu et al. · Nature | Aug 1996 | 2,013 |
| 27 | Advanced oxidation protein products as a novel marker of oxidative stress in uremia Véronique Witko‐Sarsat, Miriam A. Friedlander, Chantal Capeillère‐Blandin et al. · Kidney International | May 1996 | 2,011 |
| 28 | Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans Katherine Esposito, Francesco Nappo, Raffaele Marfella et al. · Circulation | 14 Oct 2002 | 1,987 |
| 29 | Free radical-mediated oxidation of free amino acids and amino acid residues in proteins Earl R. Stadtman, Rodney L. Levine · Amino Acids | 29 Jul 2003 | 1,970 |
| 30 | Oxidative Stress and Diabetic Vascular Complications Dario Giugliano, Antonio Ceriello, Giuseppe Paolisso · Diabetes Care | Mar 1996 | 1,938 |
| 31 | RAGE Mediates a Novel Proinflammatory Axis Marion A. Hofmann, Steven Drury, Caifeng Fu et al. · Cell | Jun 1999 | 1,871 |
| 32 | Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method Satoh Kei · Clinica Chimica Acta | Nov 1978 | 1,735 |
| 33 | Biochemistry and pathology of radical-mediated protein oxidation Roger Thornton Dean, Shanlin Fu, Roland Stocker et al. · Biochemical Journal | 15 May 1997 | 1,697 |
| 34 | Acrylamide from Maillard reaction products Richard H. Stadler, Imre Blank, Natalia Varga et al. · Nature | Oct 2002 | 1,675 |
| 35 | Diabetic Retinopathy David A. Antonetti, Ronald Klein, Thomas W. Gardner · New England Journal of Medicine | 28 Mar 2012 | 1,633 |
| 36 | Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss Ryan Yimeng Lee, Tien Yin Wong, Charumathi Sabanayagam · Eye and Vision | 29 Sep 2015 | 1,598 |
| 37 | Diabetes mellitus and oxidative stress—A concise review Asmat Ullah, Abad Khan, Khan Ismail · Saudi Pharmaceutical Journal | 5 Apr 2015 | 1,589 |
| 38 | Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein Jong Sung Park, Daiva Svetkauskaite, Qianbin He et al. · Journal of Biological Chemistry | Feb 2004 | 1,570 |
| 39 | Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. Michael P. Neeper, Ann Marie Schmidt, Jerold Brett et al. · Journal of Biological Chemistry | Jul 1992 | 1,545 |
| 40 | Advanced Glycation End Products and Diabetic Complications Varun Parkash Singh, Anjana Bali, Nirmal Singh et al. · Korean Journal of Physiology and Pharmacology | 2014 | 1,525 |
| 41 | Long-Term Complications of Diabetes Mellitus David M. Nathan · New England Journal of Medicine | 10 Jun 1993 | 1,515 |
| 42 | Are Oxidative Stress−Activated Signaling Pathways Mediators of Insulin Resistance and β-Cell Dysfunction? Joseph L. Evans, Ira D. Goldfine, Betty A. Maddux et al. · Diabetes | 2003 | 1,487 |
| 43 | Neuroinflammation: friend and foe for ischemic stroke Richard L. Jayaraj, Sheikh Azimullah, Rami Beiram et al. · Journal of Neuroinflammation | 10 Jul 2019 | 1,476 |
| 44 | What is oxidative stress? D. J. Betteridge · Metabolism | Feb 2000 | 1,458 |
| 45 | Advanced glycation endproducts—role in pathology of diabetic complications Nessar Ahmed · Diabetes Research and Clinical Practice | 4 Nov 2004 | 1,456 |
| 46 | HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection Ulf Andersson, Kevin J. Tracey · Annual Review of Immunology | Mar 2011 | 1,442 |
| 47 | HMGB1 and RAGE in Inflammation and Cancer Gary P. Sims, Daniel C. Rowe, Svend T. Rietdijk et al. · Annual Review of Immunology | Mar 2010 | 1,440 |
| 48 | RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain Rashid Deane et al. · Nature Medicine | 13 Jun 2003 | 1,429 |
| 49 | High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes Ulf Andersson, Haichao Wang, Karin Palmblad et al. · The Journal of Experimental Medicine | 21 Aug 2000 | 1,421 |
| 50 | Toll-like receptor 9–dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE Jane Y. Tian et al. · Nature Immunology | 8 Apr 2007 | 1,375 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.